Literature DB >> 8148566

Patient dose in dual x-ray absorptiometry.

M K Lewis1, G M Blake, I Fogelman.   

Abstract

Dual x-ray absorptiometry (DXA) provides a convenient, non-invasive method of assessing skeletal bone mineral which is widely used for clinical studies. This report describes a study to estimate the effective dose of radiation (ICRP-60 (1990)) to a typical female patient from scans performed on three DXA scanners: the Hologic QDR-1000, QDR-1000/W and QDR-2000. The scans modes studied were: total body; anteroposterior (AP) lumbar spine; lateral lumbar spine; proximal femur; distal forearm. An ionization chamber and tissue-equivalent phantom were used to determine entrance surface dose and percentage depth-dose curves for each scan mode. Anatomical data from ICRP-23 (Reference Man) and a body section atlas were used to estimate the absorbed dose to each organ in the scan fields. Effective dose was estimated using the ICRP-60 tissue weighting factors and the fraction of each organ in the scan field. Results are summarized below. Figures for the effective dose are given both excluding and (in brackets) including the ovaries to cover the cases of postmenopausal and premenopausal women respectively.

Entities:  

Mesh:

Year:  1994        PMID: 8148566     DOI: 10.1007/bf02352255

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  10 in total

1.  Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography.

Authors:  W A Kalender
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

Review 2.  Methods of bone mineral measurement.

Authors:  P Tothill
Journal:  Phys Med Biol       Date:  1989-05       Impact factor: 3.609

3.  Average radiation dose in standard CT examinations of the head: results of the 1990 NEXT survey.

Authors:  B J Conway; J L McCrohan; R G Antonsen; F G Rueter; R J Slayton; O H Suleiman
Journal:  Radiology       Date:  1992-07       Impact factor: 11.105

4.  Comparative performance in vitro and in vivo of Lunar DPX and Hologic QDR-1000 dual energy X-ray absorptiometers.

Authors:  M A Laskey; M E Flaxman; R W Barber; S Trafford; M P Hayball; K D Lyttle; A J Crisp; J E Compston
Journal:  Br J Radiol       Date:  1991-11       Impact factor: 3.039

5.  Effect dose equivalent in dual X-ray absorptiometry.

Authors:  D W Pye; W J Hannan; R Hesp
Journal:  Br J Radiol       Date:  1990-02       Impact factor: 3.039

6.  Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine.

Authors:  H W Wahner; W L Dunn; M L Brown; R L Morin; B L Riggs
Journal:  Mayo Clin Proc       Date:  1988-11       Impact factor: 7.616

7.  Total body studies in normal British women using dual energy X-ray absorptiometry.

Authors:  R J Herd; G M Blake; J C Parker; P J Ryan; I Fogelman
Journal:  Br J Radiol       Date:  1993-04       Impact factor: 3.039

8.  Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Geusens; C Christiansen
Journal:  Osteoporos Int       Date:  1991-06       Impact factor: 4.507

9.  X-ray dual-photon absorptiometry: a new method for the measurement of bone density.

Authors:  I D Cullum; P J Ell; J P Ryder
Journal:  Br J Radiol       Date:  1989-07       Impact factor: 3.039

10.  Performance evaluation of a dual-energy x-ray bone densitometer.

Authors:  R Mazess; B Collick; J Trempe; H Barden; J Hanson
Journal:  Calcif Tissue Int       Date:  1989-03       Impact factor: 4.333

  10 in total
  15 in total

1.  The effects of standardization and reference values on patient classification for spine and femur dual-energy X-ray absorptiometry.

Authors:  A Simmons; D E Simpson; M J O'Doherty; S Barrington; A J Coakley
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Diagnosis of vertebral fractures using a low-dose biplanar imaging system.

Authors:  K Briot; J Fechtenbaum; A Etcheto; S Kolta; A Feydy; C Roux
Journal:  Osteoporos Int       Date:  2015-06-06       Impact factor: 4.507

3.  Hologic QDR 2000 whole-body scans: a comparison of three combinations of scan modes and analysis software.

Authors:  E Spector; A LeBlanc; L Shackelford
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

4.  Patient dose in morphometric X-ray absorptiometry.

Authors:  M K Lewis; G M Blake
Journal:  Osteoporos Int       Date:  1995       Impact factor: 4.507

5.  The accuracy of volumetric bone density measurements in dual x-ray absorptiometry.

Authors:  M A Sabin; G M Blake; S M MacLaughlin-Black; I Fogelman
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

6.  Long-term performance in vitro and in vivo of dual-energy X-ray absorptiometry.

Authors:  J Y Reginster; R Deroisy; B Zegels; I Jupsin; A Albert; P Franchimont
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

7.  Total dose incurred by patients and staff from BMD measurement using a new 2D digital bone densitometer.

Authors:  V Boudousq; P O Kotzki; J M Dinten; C Barrau; C Robert-Coutant; E Thomas; D Mariano Goulart
Journal:  Osteoporos Int       Date:  2003-04-01       Impact factor: 4.507

8.  Evaluation of dual-energy X-ray absorptiometry bone mineral measurement--comparison of a single-beam and fan-beam design: the effect of osteophytic calcification on spine bone mineral density.

Authors:  H Franck; M Munz; M Scherrer
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

9.  Lateral spine dual-energy X-ray absorptiometry bone mineral measurement with fan-beam design: effect of osteophytic calcifications on lateral and anteroposterior spine BMD.

Authors:  H Franck; M Munz; M Scherrer; H v Lilienfeld-Toal
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 10.  Pediatric bone density and fracture.

Authors:  Emily von Scheven
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.